Affinity microfluidics enables high-throughput protein degradation analysis in cell-free extracts

Area of Science:

• Biochemistry
• Molecular Biology
• Biotechnology

Background:

• The ubiquitin-proteasome pathway is crucial for regulating signaling in health and disease.
• In vitro protein degradation assays are vital for understanding cellular processes but are often low-throughput and labor-intensive.
• Conventional methods like gel electrophoresis limit the speed and scale of degradation analysis.

Purpose of the Study:

• To introduce a novel microfluidic platform, protein degradation on chip (pDOC), for efficient protein degradation analysis.
• To provide a sensitive, multiplexed alternative to traditional in vitro degradation assays.
• To facilitate discovery and analysis of protein degradation in cell-free extracts.

Main Methods:

• Development of a MITOMI-based integrated microfluidic device (pDOC).
• Assaying protein degradation in hundreds of microchambers simultaneously.
• Utilizing minute amounts of reagents across various physiochemical conditions.

Main Results:

• pDOC enables rapid and simultaneous protein degradation assays.
• The platform requires significantly reduced reagent volumes compared to conventional methods.
• Achieved sensitive and multiplexed analysis of protein degradation.

Conclusions:

• pDOC offers a high-throughput, sensitive, and reagent-efficient alternative for studying protein degradation.
• This technology has significant implications for biomedical research and translational studies involving regulated proteolysis.
• Accelerates the discovery and analysis of protein degradation mechanisms.